is developing novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases.

who we are

who we are


is in partnership with CEBINA, renting office and laboratory space in the CEBINA facility, and is supported by the Business Development, R&D and Operational teams.

is collaborating with Algonist Biotechnologies on the discovery of novel chronic pain therapeutics for Algonist.